{"id":23405,"date":"2023-03-24T09:30:38","date_gmt":"2023-03-24T08:30:38","guid":{"rendered":"https:\/\/idibell.cat\/?p=23405"},"modified":"2023-03-28T12:14:48","modified_gmt":"2023-03-28T10:14:48","slug":"la-tecnologia-de-lidibell-llicenciada-a-loopdx-inicia-una-campanya-de-crowdequity","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2023\/03\/la-tecnologia-de-lidibell-llicenciada-a-loopdx-inicia-una-campanya-de-crowdequity\/","title":{"rendered":"La tecnologia de l&#8217;IDIBELL, llicenciada a LoopDx, inicia una campanya de crowdequity"},"content":{"rendered":"<p>Loop Diagnostics, tamb\u00e9 coneguda com LoopDx, una startup diagn\u00f2stica del sector MedTech nascuda a Barcelona el 2018, ha llen\u00e7at una campanya de crowdequity de 500.000 euros per completar una ronda de finan\u00e7ament de 3 milions d&#8217;euros. La resta de la inversi\u00f3 prov\u00e9 de fons europeus Next Generation (2,25 milions) i una empresa privada del sector salut.<\/p>\n<p>La ronda permetr\u00e0 a l&#8217;empresa emergent acabar la fase d&#8217;industrialitzaci\u00f3 per produir a gran escala i treure al mercat el seu test r\u00e0pid de diagn\u00f2stic d&#8217;infeccions a la sang (s\u00e8psia), capa\u00e7 d&#8217;identificar amb gran sensibilitat (86%) i especificitat (100%) despr\u00e9s de la primera hora de la infecci\u00f3. La comercialitzaci\u00f3 de la soluci\u00f3 a Espanya ser\u00e0 possible a finals d&#8217;aquest any una vegada superada la fase reguladora que l\u2019empresa emergent est\u00e0 fent actualment.<\/p>\n<p>La campanya, activa fins al 16 de maig, est\u00e0 allotjada a la plataforma d&#8217;equity crowdfunding online Capital Cell, especialitzada en biomedicina: <a href=\"https:\/\/capitalcell.es\/campaign\/loopdx\">https:\/\/capitalcell.es\/campaign\/loopdx<\/a> . Qualsevol inversor pot participar-hi amb un tiquet m\u00ednim de 500 euros.<\/p>\n<p>Aquest test va ser desenvolupat per l\u2019empersa emergent en col\u00b7laboraci\u00f3 amb en Joan Sabater, investigador de l&#8217;IDIBELL i de l&#8217;Hospital Universitari de Bellvitge. El resultat d&#8217;aquest projecte es va patentar i llicenciar a la mateixa empresa.<\/p>\n<p>Segons l&#8217;Organitzaci\u00f3 Mundial de la Salut, a dia d\u2019avui la s\u00e8psia afecta 30 milions de pacients al m\u00f3n i causa la mort de 6 milions, convertint-se en la primera causa de mort hospital\u00e0ria. Els estudis i els assaigs cl\u00ednics realitzats per la startup amb la col\u00b7laboraci\u00f3 d&#8217;hospitals de refer\u00e8ncia com l&#8217;Hospital Universitari de Bellvitge conclouen que el 40% de pacients que ingressen a les sales d&#8217;urg\u00e8ncies necessiten fer-se un hemocultiu com a prova diagn\u00f2stica per a la s\u00e8psia. A m\u00e9s, una de cada 10 persones sospitoses de patir la malaltia acaba sent positiva. En total, es detecten 175.000 casos cada any a Espanya.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;investigador de l&#8217;IDIBELL i de l&#8217;Hospital Universitari de Bellvitge Joan Sabater, en col\u00b7laboraci\u00f3 amb la startup LoopDx, va desenvolupar entre el 2018 i el 2019 SeptiLoop, un kit de diagn\u00f2stic r\u00e0pid de s\u00e8psia. El resultat d&#8217;aquest projecte es va patentar i llicenciar a la mateixa empresa.<\/p>\n","protected":false},"author":8,"featured_media":23407,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,493],"tags":[],"class_list":["post-23405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","category-innovacio"],"publishpress_future_action":{"enabled":false,"date":"2024-09-14 23:09:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23405"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=23405"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23405\/revisions"}],"predecessor-version":[{"id":23408,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/23405\/revisions\/23408"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/23407"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=23405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=23405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=23405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}